I think with the combination of the growing list of big name companies dropping out of s/c trials, along with the strategy Cytodyn has implemented with their consultant out in the field plus their “Covid advisory team” of doctors who have actually used the drug on patients, the traction will be much better. But I agree, time will tell if my belief is correct or not ,